← 홈

ADC

1,068개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,068개
ADCBiologicAstellasvedotin (ARON-2EV study)Phase 2

EV (Enfortumab vedotin-ejfv, Enfortumab vedotin-ejfv (EV))

Urothelial Cancer; Metastatic Urothelial Carcinoma · Urothelial Cancer

#UrothelialCancer#ADC#Phase2#인기#항체약물접합체+5
임상시험 67상태 RECRUITING
ADCBiologicAstraZenecaVedotin in a Hemodialysis P…Phase 3

Gemcitabine/Carboplatin (Gemcitabine/Carboplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 69.6%임상시험 67상태 ACTIVE
ADCBiologicAstraZenecaPhase 3

Pemetrexed/Carboplatin (Pemetrexed/Carboplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 87.5%임상시험 67상태 RECRUITING
ADCBiologicAstraZenecaPhase 3

Carboplatin/Paclitaxel (Carboplatin/Paclitaxel)

Advanced Ovarian Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 75%임상시험 66상태 RECRUITING
ADCBiologicRemeGenvedotin plus PD-1 blockade …Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin(RC48) Plus Tratuzumab)

HER2-positive Gastric Cancer; HER2-positive Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
임상시험 66상태 RECRUITING
ADCBiologicPfizerderuxtecan improved objecti…Phase 2

Encorafenib (Encorafenib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Dynamic Tumor Resistance

#DynamicTumorResistance#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 66.7%임상시험 66상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCvedotin combined with pembr…Phase 2

Immune Checkpoint Inhibitor (Immune Checkpoint Inhibitor)

Unspecified Adult Solid Tumor, Protocol Specific · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 59%임상시험 66상태 RECRUITING
ADCBiologicPETHEMA Foundationvedotin efficacy in DLBCL w…Approved

R-CHOP (R-CHOP)

HIV Infections; Diffuse Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma (DLBCL)

#DiffuseLargeBCellLymphomaDLBCL#ADC#Approved#인기#항체약물접합체+5
효능 ORR 95%임상시험 66상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCPhase 3

Rescue medications (Rescue medications)

Lung Neoplasm Malignant · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#인기#항체약물접합체+4
임상시험 66상태 RECRUITING
ADCBiologicNovartis PharmaceuticalsPhase 2

Ribociclib (Ribociclib)

KRAS G12C Mutant Solid Tumors; Carcinoma, Non-Small Cell Lung · Breast Cancer

#BreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 66.7%임상시험 66상태 RECRUITING
ADCBiologicDaiichi SankyoDM1) and trastuzumab deruxt…Phase 3

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201)

Breast Cancer; HER2-positive Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 65.8%임상시험 66상태 RECRUITING
ADCBiologicAlterome Therapeutics, Inc.sPhase 1

midazolam (midazolam)

Cancer; PDAC - Pancreatic Ductal Adenocarcinoma · Carcinomas

#Carcinomas#ADC#Phase1#인기#항체약물접합체+5
임상시험 66상태 ACTIVE
ADCBiologicBristol-Myers SquibbPhase 2

6-mercaptopurine (6-mercaptopurine)

Inflammatory Bowel Disease; Ulcerative Colitis · Precursor Cell Lymphoblastic Leukemia-Ly

#PrecursorCellLymphoblasticLeukem#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 22%임상시험 65상태 RECRUITING
ADCBiologicEuropean Organisation for Resea…Phase 2

Ara C (Ara C)

Lymphoma; Leukemia · CLASSICAL HODGKIN LYMPHOMA

#CLASSICALHODGKINLYMPHOMA#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 45.2%임상시험 65상태 ACTIVE
ADCBiologicMerck Sharp & Dohme LLCPhase 2

Corticosteroid (Corticosteroid)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 5.6%임상시험 65상태 RECRUITING
ADCBiologicPfizerthatPhase 2

Gemtuzumab Ozogamicin (Gemtuzumab Ozogamicin)

Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 0%임상시험 65상태 RECRUITING
ADCBiologicEli Lilly and CompanyDXdPhase 1

Itraconazole (Itraconazole)

Ovarian Neoplasms; Endometrial Neoplasms · Fallopian Tube Cancer

#FallopianTubeCancer#ADC#Phase1#인기#항체약물접합체+5
효능 ORR 10.5%임상시험 65상태 RECRUITING
ADCBiologicHoffmann-La RochePhase 2

Xeloda (Xeloda)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#인기#항체약물접합체+2
효능 ORR 30%임상시험 65상태 RECRUITING
ADCBiologicDaiichi SankyoreleasePhase 1

DP1 (DS-8201a, DS-8201a (DP1))

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#인기#항체약물접합체+4
효능 ORR 79.7%임상시험 64상태 ACTIVE
ADCBiologicCaicun ZhouSN-38, indicated by higher …Phase 2

Gefitinib (Gefitinib)

Non-small-cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 74.9%임상시험 64상태 ACTIVE

6 / 54 페이지

← 이전다음 →